Press releases
- Elanco Provides Innovation Update
- Elanco to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
- Elanco Announces FDA Has Completed Review of Bovaer®, First-in-Class Methane-Reducing Feed Ingredient, for U.S. Dairy Industry
- Elanco to Participate in Stifel 2024 Jaws and Paws Conference
- Elanco Animal Health Reports First Quarter 2024 Results
- Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
- Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
- Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
More ▼
Key statistics
On Friday, Elanco Animal Health Inc (5EA:DEU) closed at 13.74, -20.32% below its 52-week high of 17.25, set on Jun 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.27 |
---|---|
High | 14.50 |
Low | 13.21 |
Bid | 13.40 |
Offer | 13.54 |
Previous close | 12.87 |
Average volume | 1.16k |
---|---|
Shares outstanding | 494.18m |
Free float | 490.93m |
P/E (TTM) | -- |
Market cap | 7.13bn USD |
EPS (TTM) | -2.64 USD |
Data delayed at least 15 minutes, as of Jun 28 2024.
More ▼